A 10026 (see companion bill S 8384) – New YorkStatus: Inactive / Dead
Year Introduced: 2018
PHARMACY BENEFIT MANAGER TRANSPARENCY ACT: A pharmacy benefit manager shall notify a covered entity in writing of any activity, policy, practice, ownership, interest, or affiliation of the pharmacy benefit manager that presents a conflict on interest that interferes with the requirements imposed by this article. Each PBM under contract with a covered entity shall submit to the covered entity and to the superintendent: (A) the wholesale acquisition cost for each drug on its formulary and the total number of prescriptions that were dispensed. (B) the amount of rebates, discounts, and price concessions that the PBM received for each drug on its formulary.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.